BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

500009

AMBALALSA

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

AMBALAL SARABHAI ENTERPRISES L Share Price Update

As of the latest trading session, AMBALAL SARABHAI ENTERPRISES L share price is currently at ₹ 36.46, which is down by ₹ -0.63 from its previous closing. Today, the stock has fluctuated between ₹ 36.27 and ₹ 37.45. Over the past year, AMBALAL SARABHAI ENTERPRISES L has achieved a return of -21.42 %. In the last month alone, the return has been 0.85 %. Read More...

AMBALAL SARABHAI ENTERPRISES L fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    279.40

  • P/E Ratio (TTM)

    15.58

  • Beta

    1.54

  • Book Value / share

    5.88

  • Return on equity

    1.80%

  • EPS (TTM)

    1.66

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    8.43

info icon alternate text

AMBALAL SARABHAI ENTERPRISES L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 1.17
Operating Expense 3.86
Net Profit 8.43
Net Profit Margin (%) 720.51
Earnings Per Share (EPS) 1.10
EBITDA 8.23
Effective Tax Rate (%) -3.94
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 1.91
Net Profit 4.31
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.56
EBITDA 4.58
Effective Tax Rate (%) 3.36
Particulars JUN 2024 (Values in Cr)
Revenue 1.14
Operating Expense 2.52
Net Profit 0.46
Net Profit Margin (%) 40.35
Earnings Per Share (EPS) 0.06
EBITDA 0.61
Effective Tax Rate (%) 6.12
Particulars MAR 2024 (Values in Cr)
Revenue 0.99
Operating Expense 1.75
Net Profit 4.70
Net Profit Margin (%) 474.74
Earnings Per Share (EPS) 0.62
EBITDA 2.76
Effective Tax Rate (%) -76.69
Particulars DEC 2023 (Values in Cr)
Revenue 0.33
Operating Expense 2.04
Net Profit -0.65
Net Profit Margin (%) -196.96
Earnings Per Share (EPS) -0.08
EBITDA -0.29
Effective Tax Rate (%) -71.05
Particulars MAR 2024 (Values in Cr)
Revenue 3.81
Operating Expense 10.88
Net Profit 2.58
Net Profit Margin (%) 67.71
Earnings Per Share (EPS) 0.34
EBITDA 1.12
Effective Tax Rate (%) -218.51
Particulars MAR 2023 (Values in Cr)
Revenue 3.71
Operating Expense 9.12
Net Profit 4.11
Net Profit Margin (%) 110.78
Earnings Per Share (EPS) 0.54
EBITDA 4.60
Effective Tax Rate (%) 5.29
Particulars MAR 2022 (Values in Cr)
Revenue 0.13
Operating Expense 6.14
Net Profit 2.96
Net Profit Margin (%) 2276.92
Earnings Per Share (EPS) 0.39
EBITDA 3.89
Effective Tax Rate (%) 14.49
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 39.08
Net Profit -9.39
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -1.22
EBITDA -8.53
Effective Tax Rate (%) 0.84
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 8.70
Net Profit 15.55
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 2.03
EBITDA 16.75
Effective Tax Rate (%) 2.20
Particulars MAR 2024 (Values in Cr)
Book Value / Share 17.89
ROE % 3.98
ROCE % 6.73
Total Debt to Total Equity 0.34
EBITDA Margin 9.40
Particulars MAR 2023 (Values in Cr)
Book Value / Share 17.08
ROE % 8.01
ROCE % 9.92
Total Debt to Total Equity 0.29
EBITDA Margin 12.12
Particulars MAR 2022 (Values in Cr)
Book Value / Share 15.64
ROE % 24.23
ROCE % 24.22
Total Debt to Total Equity 0.28
EBITDA Margin 22.45
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.64
ROE % 8.14
ROCE % 9.19
Total Debt to Total Equity 0.49
EBITDA Margin 11.36
Particulars MAR 2020 (Values in Cr)
Book Value / Share 5.84
ROE % 9.78
ROCE % 10.15
Total Debt to Total Equity 0.94
EBITDA Margin 15.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share 5.26
ROE % 1.80
ROCE % 1.92
Total Debt to Total Equity 0.28
EBITDA Margin 81.10
Particulars MAR 2023 (Values in Cr)
Book Value / Share 4.94
ROE % 3.35
ROCE % 3.35
Total Debt to Total Equity 0.30
EBITDA Margin 143.13
Particulars MAR 2022 (Values in Cr)
Book Value / Share 4.40
ROE % 3.89
ROCE % 4.31
Total Debt to Total Equity 0.32
EBITDA Margin 3407.69
Particulars MAR 2021 (Values in Cr)
Book Value / Share 4.02
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.31
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 5.25
ROE % 18.49
ROCE % 16.81
Total Debt to Total Equity 0.34
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 32.90
Total Assets 250.22
Total Liabilities 250.22
Total Equity 137.13
Share Outstanding 76633296
Price to Book Ratio 8.65
Return on Assets (%) 2.27
Return on Capital (%) 3.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 28.08
Total Assets 245.74
Total Liabilities 245.74
Total Equity 130.92
Share Outstanding 76633296
Price to Book Ratio 4.15
Return on Assets (%) 4.65
Return on Capital (%) 6.57
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 28.25
Total Assets 230.50
Total Liabilities 230.50
Total Equity 119.85
Share Outstanding 76633296
Price to Book Ratio 7.93
Return on Assets (%) 20.48
Return on Capital (%) 32.46
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 31.37
Total Assets 210.05
Total Liabilities 210.05
Total Equity 73.88
Share Outstanding 76633296
Price to Book Ratio 4.39
Return on Assets (%) 13.97
Return on Capital (%) 28.91
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 21.53
Total Assets 186.44
Total Liabilities 186.44
Total Equity 44.75
Share Outstanding 76633296
Price to Book Ratio 3.63
Return on Assets (%) 7.54
Return on Capital (%) 19.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.01
Total Assets 81.28
Total Liabilities 81.28
Total Equity 40.29
Share Outstanding 76633296
Price to Book Ratio 8.65
Return on Assets (%) 3.17
Return on Capital (%) 5.13
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.45
Total Assets 79.74
Total Liabilities 79.74
Total Equity 37.84
Share Outstanding 76633296
Price to Book Ratio 4.15
Return on Assets (%) 5.15
Return on Capital (%) 8.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 5.08
Total Assets 82.98
Total Liabilities 82.98
Total Equity 33.70
Share Outstanding 76633296
Price to Book Ratio 7.93
Return on Assets (%) 3.56
Return on Capital (%) 6.8
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 8.54
Total Assets 100.04
Total Liabilities 100.04
Total Equity 30.78
Share Outstanding 76633296
Price to Book Ratio 4.39
Return on Assets (%) -9.38
Return on Capital (%) -22.39
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 4.49
Total Assets 124.59
Total Liabilities 124.59
Total Equity 40.24
Share Outstanding 76633296
Price to Book Ratio 3.63
Return on Assets (%) 12.48
Return on Capital (%) 30.34
Particulars MAR 2024 (Values in Cr)
Net Income 6.65
Cash from Operations 8.71
Cash from Investing -1.12
Cash from Financing -2.94
Net change in Cash 0.64
Free Cash Flow 11.82
Particulars MAR 2023 (Values in Cr)
Net Income 15.17
Cash from Operations 10.14
Cash from Investing -16.78
Cash from Financing 9.08
Net change in Cash -1.97
Free Cash Flow 30.80
Particulars MAR 2022 (Values in Cr)
Net Income 54.19
Cash from Operations 15.02
Cash from Investing 5.07
Cash from Financing -19.18
Net change in Cash -2.63
Free Cash Flow 29.35
Particulars MAR 2021 (Values in Cr)
Net Income 32.54
Cash from Operations -0.34
Cash from Investing 10.08
Cash from Financing -5.84
Net change in Cash 1.95
Free Cash Flow 2.11
Particulars MAR 2020 (Values in Cr)
Net Income 14.93
Cash from Operations -4.39
Cash from Investing 16.88
Cash from Financing -14.21
Net change in Cash -4.20
Free Cash Flow -0.72
Particulars MAR 2024 (Values in Cr)
Net Income 0.81
Cash from Operations -3.13
Cash from Investing 3.47
Cash from Financing 0.29
Net change in Cash -0.04
Free Cash Flow -3.04
Particulars MAR 2023 (Values in Cr)
Net Income 4.33
Cash from Operations 2.30
Cash from Investing 0.60
Cash from Financing -3.76
Net change in Cash -1.63
Free Cash Flow 2.34
Particulars MAR 2022 (Values in Cr)
Net Income 3.45
Cash from Operations -7.16
Cash from Investing 20.77
Cash from Financing -16.45
Net change in Cash -3.47
Free Cash Flow -7.13
Particulars MAR 2021 (Values in Cr)
Net Income -9.46
Cash from Operations -9.98
Cash from Investing 15.76
Cash from Financing -0.31
Net change in Cash 5.02
Free Cash Flow -9.70
Particulars MAR 2020 (Values in Cr)
Net Income 15.90
Cash from Operations -4.04
Cash from Investing 4.91
Cash from Financing -0.41
Net change in Cash -0.03
Free Cash Flow -3.70
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95
ABBOTT INDIA LIMITED 29876.95 47.58 18.03 63488.52 25260.20 / 31900.00

AMBALAL SARABHAI ENTERPRISES L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
36.46 -1.72 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 37.50
  • 26 Days 38.20
  • 10 Days 37.90
  • 50 Days 40.20
  • 12 Days 37.90
  • 100 Days 44.50
  • 20 Days 38.00
  • 200 Days 48.00
37.43 PIVOT

First Support

36.67

First Resistance

37.87

Second Support

36.23

Second Resistance

38.63

Third Support

35.47

Third Resistance

39.07

RSI

41.54

ADX

39.03

MACD

-0.30

Williams % R

-92.47

Commodity Channel Index (CCI)

-66.37

Date

2025-04-30

Week

69408.00

Same Day

32906.00

Month

87529.00

1 Year

1.55

3 Year

1.02

Over 1 Month

0.85%

down

Over 1 Year

-21.42%

down

Over 3 Months

-23.91%

down

Over 3 Years

0.98%

down

Over 6 Months

-35.67%

down

Over 5 Years

14.28%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

AMBALAL SARABHAI ENTERPRISES L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
68.17%
Promoter Holdings
31.34%
FII
0.37%
DII
0.1%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Sarabhai Holdings Private Limited 1.9742348E7 (25.76%) Shareholding of Promoter and Promoter Group
Haryana Containers Limited 1232388.0 (1.61%) Public Shareholding
Sharad Kanayalal Shah 800000.0 (1.04%) Public Shareholding
Yudhisthar Investments Pvt Ltd Ivl 469305.0 (0.61%) Shareholding of Promoter and Promoter Group
Koshalya Investments Pvt Ltd Ivl 456722.0 (0.6%) Shareholding of Promoter and Promoter Group
Kanda Investments Pvt.ltd.(ivl) 209288.0 (0.27%) Shareholding of Promoter and Promoter Group
Vasantbahar Investments Pvt.ltd.(ivl) 200989.0 (0.26%) Shareholding of Promoter and Promoter Group
Vaishakhi Investments Pvt.ltd.(ivl) 181561.0 (0.24%) Shareholding of Promoter and Promoter Group
Ashavari Investments Pvt.ltd.(ivl) 182513.0 (0.24%) Shareholding of Promoter and Promoter Group
Todirag Holdings Pvt.ltd.(ivl) 185675.0 (0.24%) Shareholding of Promoter and Promoter Group
Madhavbag Holdings Pvt.ltd.(ivl) 178651.0 (0.23%) Shareholding of Promoter and Promoter Group
Jonpuri Investments Pvt.ltd.(ivl) 178667.0 (0.23%) Shareholding of Promoter and Promoter Group
Mrigank Investments Pvt.ltd.(ivl) 178669.0 (0.23%) Shareholding of Promoter and Promoter Group
Rajka Designs Private Limited 171100.0 (0.22%) Shareholding of Promoter and Promoter Group
Medicinal Drugs Mfg.pvt.ltd.(ivl) 157716.0 (0.21%) Shareholding of Promoter and Promoter Group
Adana Investments Pvt.ltd.(ivl) 157920.0 (0.21%) Shareholding of Promoter and Promoter Group
Bilawal Investments Pvt.ltd.(ivl) 157920.0 (0.21%) Shareholding of Promoter and Promoter Group
Bhadrapad Investments Pvt.ltd.(ivl) 157920.0 (0.21%) Shareholding of Promoter and Promoter Group
Khamaj Investments Pvt.ltd.(ivl) 159086.0 (0.21%) Shareholding of Promoter and Promoter Group
Sahayog Investments Pvt.ltd.(ivl) 161011.0 (0.21%) Shareholding of Promoter and Promoter Group
Talimi Investments Pvt.ltd.(ivl) 163323.0 (0.21%) Shareholding of Promoter and Promoter Group
Leena Investments Pvt Ltd Ivl 128217.0 (0.17%) Shareholding of Promoter and Promoter Group
Mallika Vikram Sarabhai 127073.0 (0.17%) Shareholding of Promoter and Promoter Group
Kartikeya Vikram Sarabhai 126346.0 (0.16%) Shareholding of Promoter and Promoter Group
Sarabhai Management Corporation Pvt Ltd 91634.0 (0.12%) Shareholding of Promoter and Promoter Group
Mohal Kartikeya Sarabhai 51387.0 (0.07%) Shareholding of Promoter and Promoter Group
Samvit Kartikeya Sarabhai 44540.0 (0.06%) Shareholding of Promoter and Promoter Group
Himalaya Ivestments Pvt.ltd.(ivl) 1911.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

AMBALAL SARABHAI ENTERPRISES L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

AMBALAL SARABHAI ENTERPRISES L Share Price

Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multi-dimensional businesses. Each subsidiary is a distinct entity contributing its unique expertise and capabilities. It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally. ASE's strength is to lead with cutting edge technology by creating strategic technology tie-ups and collaborative partnerships through our broad national and international networks

The Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. It operates in two segments, pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services.

In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections.

During the year 1997-98, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 1998-99, the company signed agreement with B V Chiron, Netherlands for introducing their anti-cancer drugs in India.

During the year 1999-2000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The Product Division essentially comprising of Sarabai Chemicals Products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd.

In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division re-launched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd.

During the year 2008-09, the Oncology Division launched two new products viz. Fludagem & Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent Drug Delivery System.

During the year 2010-11, the Company had transferred and assigned as going concern, the business undertaking of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and Electronics Division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010.

Sarabhai M Chemicals Ltd, a wholly owned subsidiary company started its Vitamin C coated products manufacturing since August 2019.

In June 2023, Asence Pharma Pvt., Ltd. a subsidiary of the Company commenced its new oncology and synthetic API plant at Ranoli, Vadodara.

Parent organization Sarabhai Ent
NSE symbol AMBASARABH
Founded 1977
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Ambalal Sarabhai Enterprises Ltd?

Answer Field

The share price of Ambalal Sarabhai Enterprises Ltd for NSE is ₹ 4.25 and for BSE is ₹ 36.46.

What is the Market Cap of Ambalal Sarabhai Enterprises Ltd?

Answer Field

The market cap of Ambalal Sarabhai Enterprises Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 2,79.40 Cr. as of now.

What is the 52 Week High and Low of Ambalal Sarabhai Enterprises Ltd?

Answer Field

The 52 Week High and Low of Ambalal Sarabhai Enterprises Ltd for NSE is ₹ 4.60 and ₹ 0.00 and for BSE is ₹ 77.70 and ₹ 34.11.

How to Buy Ambalal Sarabhai Enterprises Ltd share?

Answer Field

You can trade in Ambalal Sarabhai Enterprises Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Ambalal Sarabhai Enterprises Ltd?

Answer Field

The 1 year returns on the stock has been -21.42%.

What is the Current Share Price of Ambalal Sarabhai Enterprises Ltd?

Answer Field

Ambalal Sarabhai Enterprises Ltd share price is for NSE ₹ 4.25 & for BSE ₹ 36.46 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Ambalal Sarabhai Enterprises Ltd Share?

Answer Field

The market cap of Ambalal Sarabhai Enterprises Ltd for NSE ₹ 0.0 & for BSE ₹ 2,79.40 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Ambalal Sarabhai Enterprises Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Ambalal Sarabhai Enterprises Ltd share is 15.58.

What is the PB ratio of Ambalal Sarabhai Enterprises Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Ambalal Sarabhai Enterprises Ltd share is 5.88.

How to Buy Ambalal Sarabhai Enterprises Ltd Share?

Answer Field

You can trade in Ambalal Sarabhai Enterprises Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ambalal Sarabhai Enterprises Ltd Share on Bajaj Broking App?

Answer Field

To buy Ambalal Sarabhai Enterprises Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ambalal Sarabhai Enterprises Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|